NVS Aug 2024 100.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:46PM EDT. Market open.
Loading interactive chart…
- Investor's Business Daily
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
A renaissance is stirring in cholesterol treatment, and it could drive Merck, Novartis and other stocks higher, while delivering new choices for millions of patients.
- Zacks
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
The FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat adults with familial chylomicronemia syndrome. A final decision is expected in December 2024.
- Investor's Business Daily
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
A Relative Strength Rating upgrade for Novartis ADR shows improving technical performance. Will it continue?
© 2024 Yahoo. All rights reserved.